Colorectal cancer Cancer Malignant neoplasm of colon
Conditions
Interventions
The intervention will be in the form of an oral supplement, if patients can tolerate milky drinks Fortisip Compact® (Nutricia Clinical Care) will be used. Patients will be offered a minimum of 250mls
Sponsors
University of Manchester (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Reported weigh loss over the previous 6 months 2. Primary colorectal tumour, eligible for curative surgery 3. Informed consent gained
Exclusion criteria
Exclusion criteria: 1. Pregnant or enrolled in another trial 2. Pacemaker and any metallic implant will preclude individuals from bioelectrical impedance monitoring 3. Cannot give informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of postoperative chest and surgical site infections after CRC surgery, measured from patient medical records reviewed within 30 days after surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| As of 17/03/2016: 1. Total complications measured up to 30 days postoperatively 2. Anthropometry 3. Body composition and dietary intake Measured at baseline, 2-3 days preoperatively (where possible) and 7-10 days postoperatively (where possible). Initial 1. Anthropometry ? height, weight, body mass index, mid arm circumference (MAC) and skin fold thickness 2. Hand grip strength 3. Co-morbidities 4. 24 hour recalls to assess energy and protein 5. Hospital anxiety and depression score Measured at baseline, 24 hours preoperatively, 7 days post-operatively and at 3 months | — |
Countries
United Kingdom
Outcome results
None listed